Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Interest Income - Total: 2021-2025

Historic Interest Income - Total for Abeona Therapeutics (ABEO) over the last 4 years, with Sep 2025 value amounting to $1.7 million.

  • Abeona Therapeutics' Interest Income - Total rose 40.62% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 26.88%. This contributed to the annual value of $4.2 million for FY2024, which is 100.57% up from last year.
  • Latest data reveals that Abeona Therapeutics reported Interest Income - Total of $1.7 million as of Q3 2025, which was up 62.80% from $1.0 million recorded in Q2 2025.
  • Over the past 5 years, Abeona Therapeutics' Interest Income - Total peaked at $1.7 million during Q3 2025, and registered a low of $5,000 during Q4 2021.
  • Over the past 3 years, Abeona Therapeutics' median Interest Income - Total value was $1.0 million (recorded in 2024), while the average stood at $942,909.
  • Per our database at Business Quant, Abeona Therapeutics' Interest Income - Total skyrocketed by 6,460.00% in 2022 and then fell by 13.77% in 2025.
  • Quarterly analysis of 5 years shows Abeona Therapeutics' Interest Income - Total stood at $5,000 in 2021, then soared by 6,460.00% to $328,000 in 2022, then spiked by 126.52% to $743,000 in 2023, then surged by 37.69% to $1.0 million in 2024, then soared by 40.62% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $1.0 million for Q2 2025, and $1.3 million during Q1 2025.